Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Clinical trial NCT06961669 · RECRUITING

Trial details

NCT number: NCT06961669
Sponsor: Anhui Provincial Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Lymphoblastic Leukemia Relapsed or Refractory Multiple Myeloma (RRMM)

Start date: 2025-04-16
Primary completion: 2028-08-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.